Clinical data | The number of cases (%) | |
Sex | male | 26 (50.98) |
female | 25 (49.02) | |
Age | <40 years | 9 (17.64) |
40 - 59 years | 34 (66.67) | |
≥60 years | 8 (15.69) | |
Preoperative complications | hypertension | 8 (15.69) |
diabetes | 1 (1.96) | |
thyroid disease | 1 (1.96) | |
heart disease | 1 (1.96) | |
none | 41 (80.39) | |
Incidence | starting | 46 (90.2) |
relapse | 5 (9.80) | |
Tumor size | large adenoma | 46 (90.20) |
giant adenoma | 5 (9.80) | |
Tumour texture | soft | 29 (56.86) |
tough | 22 (43.14) | |
Tumour blood supply | rich blood supply | 28 (54.90) |
blood for general | 23 (45.10) | |
| 0 | 3 (5.88) |
| I | 14 (27.45) |
Knops classification | II | 19 (37.25) |
| III | 10 (19.61) |
| IV | 5 (9.81) |
The extent of tumor resection | full cut | 49 (96.08) |
subtotal cut | 2 (3.92) | |
Pathological classification | ACTH | 2 (3.92) |
FSH | 2 (3.92) | |
GH | 7 (13.73) | |
GH and ACTH mixed | 1 (1.96) | |
NFPA | 33 (64.71) | |
PRL | 4 (7.84) | |
TSH | 1 (1.96) | |
TSH and FSH mixed | 1 (1.96) | |
Degree of cerebrospinal fluid leakage | low-flow leakage | 46 (90.20) |
high-flow leakage | 5 (9.80) | |
Intraoperative sellar floor reconstruction | simple sellar floor reconstruction | 6 (11.76) |
multilayer sellar floor reconstruction | 45 (88.24) |